Senthil Vel Sundaram's Net Worth
$3.31 Million
Who is Senthil Vel Sundaram?
Senthil Vel Sundaram has an estimated net worth of $3.31 Million. This is based on reported shares across multiple companies, which include Social Capital Suvretta Holdings Corp. I, Nightstar Therapeutics plc, Terns Pharmaceuticals, Inc., and Axovant Gene Therapies Ltd..
SEC CIK
Senthil Vel Sundaram's CIK is 0001762316
Past Insider Trading and Trends
2022 was Senthil Vel Sundaram's most active year for acquiring shares with 3 total transactions. Senthil Vel Sundaram's most active month to acquire stocks was the month of December. 2019 was Senthil Vel Sundaram's most active year for disposing of shares, totalling 5 transactions. Senthil Vel Sundaram's most active month to dispose stocks was the month of May. 2022 saw Senthil Vel Sundaram paying a total of $11,258.55 for 287,659 shares, this is the most they've acquired in one year. In 2019 Senthil Vel Sundaram cashed out on 296,383 shares for a total of $5,095,971.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Social Capital Suvretta Holdings Corp. I (AKLI) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nightstar Therapeutics plc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -126.89K |
$25.50 | -$3,235,593.00 |
0
|
Jun 7
| |||
Form 4
| -0.31% | -391.00 |
$25.31 | -$9,896.21 | 126.89K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| -0.32% | -406.00 |
$12.98 | -$5,270.20 | 127.28K |
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $7.99
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.56% | 2.11K |
$1.41 | $2,976.51 | 9.77K |
May 31
| |||
Form 4
| +0.04% | 3 |
$1.41 | $4.23 | 7.66K |
Nov 30 - Feb 1
| |||
Form 4
|
∞
| 7.66K |
$1.47 | $11,254.32 | 7.66K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sio Gene Therapies Inc. (SIOX) Snapshot price: $0.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |